1 study found for:    18948947 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Condition: Carcinoma of the Lung.
Interventions: Drug: Binimetinib;   Drug: Pemetrexed;   Drug: Carboplatin

Indicates status has not been verified in more than two years